Literature DB >> 15036616

Calcineurin-mediated BAD Ser155 dephosphorylation in ammonia-induced apoptosis of cultured rat hippocampal neurons.

Li Yang1, Kyoko Omori, Junko Suzukawa, Chiyoko Inagaki.   

Abstract

We previously reported that ammonia induced apoptosis in cultured rat hippocampal neurons with moderate increases in the intracellular calcium concentration and decreases in phospho-BAD levels. Since this suggested the involvement of calcineurin in the apoptosis, the effects of calcineurin inhibitors, 1 microM cyclosporin A and 1 microM FK506, on the ammonia-induced neuronal apoptosis were tested. Both of the inhibitors abolished the neuronal apoptosis assessed by double staining with Hoechst 33258 and anti-neurofilament antibody, and the ammonia-induced decrease in phospho-BAD Ser(155) level. Thus, calcineurin appeared to be involved in the dephosphorylation of BAD at the sites including Ser(155) in ammonia-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15036616     DOI: 10.1016/j.neulet.2003.12.032

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  15 in total

1.  α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases.

Authors:  Zane S Martin; Volker Neugebauer; Kelly T Dineley; Rakez Kayed; Wenru Zhang; Lindsay C Reese; Giulio Taglialatela
Journal:  J Neurochem       Date:  2011-11-28       Impact factor: 5.372

2.  Astrocytes protect neurons from ammonia toxicity.

Authors:  K V Rama Rao; K S Panickar; A R Jayakumar; M D Norenberg
Journal:  Neurochem Res       Date:  2005-10       Impact factor: 3.996

Review 3.  Mechanisms of noise-induced hearing loss indicate multiple methods of prevention.

Authors:  Colleen G Le Prell; Daisuke Yamashita; Shujiro B Minami; Tatsuya Yamasoba; Josef M Miller
Journal:  Hear Res       Date:  2006-12-04       Impact factor: 3.208

Review 4.  Role of calcineurin in neurodegeneration produced by misfolded proteins and endoplasmic reticulum stress.

Authors:  Abhisek Mukherjee; Claudio Soto
Journal:  Curr Opin Cell Biol       Date:  2011-02-02       Impact factor: 8.382

5.  BAD phosphorylation determines ovarian cancer chemosensitivity and patient survival.

Authors:  Douglas C Marchion; Hope M Cottrill; Yin Xiong; Ning Chen; Elona Bicaku; William J Fulp; Nisha Bansal; Hye Sook Chon; Xiaomang B Stickles; Siddharth G Kamath; Ardeshir Hakam; Lihua Li; Dan Su; Carolina Moreno; Patricia L Judson; Andrew Berchuck; Robert M Wenham; Sachin M Apte; Jesus Gonzalez-Bosquet; Gregory C Bloom; Steven A Eschrich; Said Sebti; Dung-Tsa Chen; Johnathan M Lancaster
Journal:  Clin Cancer Res       Date:  2011-08-17       Impact factor: 12.531

6.  Mitochondrial targeting of cyclosporin A enables selective inhibition of cyclophilin-D and enhanced cytoprotection after glucose and oxygen deprivation.

Authors:  Sylvanie Malouitre; Henry Dube; David Selwood; Martin Crompton
Journal:  Biochem J       Date:  2009-12-14       Impact factor: 3.857

7.  Selective induction of calcineurin activity and signaling by oligomeric amyloid beta.

Authors:  Lindsay C Reese; WenRu Zhang; Kelly T Dineley; Rakez Kayed; Giulio Taglialatela
Journal:  Aging Cell       Date:  2008-09-08       Impact factor: 9.304

Review 8.  A central role for calcineurin in protein misfolding neurodegenerative diseases.

Authors:  Syed Zahid Ali Shah; Tariq Hussain; Deming Zhao; Lifeng Yang
Journal:  Cell Mol Life Sci       Date:  2016-09-28       Impact factor: 9.261

9.  The BCL2 antagonist of cell death pathway influences endometrial cancer cell sensitivity to cisplatin.

Authors:  Hye Sook Chon; Douglas C Marchion; Yin Xiong; Ning Chen; Elona Bicaku; Xiaomang Ba Stickles; Nadim Bou Zgheib; Patricia L Judson; Ardeshir Hakam; Jesus Gonzalez-Bosquet; Robert M Wenham; Sachin M Apte; Johnathan M Lancaster
Journal:  Gynecol Oncol       Date:  2011-10-26       Impact factor: 5.482

10.  BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin.

Authors:  Nisha Bansal; Douglas C Marchion; Elona Bicaku; Yin Xiong; Ning Chen; Xiaomang B Stickles; Entidhar Al Sawah; Robert M Wenham; Sachin M Apte; Jesus Gonzalez-Bosquet; Patricia L Judson; Ardeshir Hakam; Johnathan M Lancaster
Journal:  J Gynecol Oncol       Date:  2012-01-09       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.